VKTX
Viking Therapeutics Inc
Price:  
32.01 
USD
Volume:  
3,385,835.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VKTX Intrinsic Value

-117.84 %
Upside

What is the intrinsic value of VKTX?

As of 2025-07-19, the Intrinsic Value of Viking Therapeutics Inc (VKTX) is -5.71 USD. This VKTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 32.01 USD, the upside of Viking Therapeutics Inc is -117.84%.

Is VKTX undervalued or overvalued?

Based on its market price of 32.01 USD and our intrinsic valuation, Viking Therapeutics Inc (VKTX) is overvalued by 117.84%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

32.01 USD
Stock Price
-5.71 USD
Intrinsic Value
Intrinsic Value Details

VKTX Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -5.71 - -5.71 -5.71 -117.84%
P/E (19.71) - (27.36) (24.41) -176.2%
DDM - Stable (7.74) - (28.34) (18.04) -156.4%
DDM - Multi (0.19) - (0.55) (0.29) -100.9%

VKTX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,595.04
Beta 1.31
Outstanding shares (mil) 112.31
Enterprise Value (mil) 3,557.10
Market risk premium 4.60%
Cost of Equity 10.98%
Cost of Debt 5.00%
WACC 7.32%